Seyed Mohammad Taghdisi Selected Research

Esters

9/2023	Self-targeted hyaluronic acid-b-poly (β-amino ester) pH-switchable polymersome for guided doxorubicin delivery to metastatic breast cancer.
3/2019	A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyed Mohammad Taghdisi Research Topics

Disease

82	Neoplasms (Cancer) 04/2024 - 02/2011
21	Breast Neoplasms (Breast Cancer) 02/2024 - 06/2015
12	Colonic Neoplasms (Colon Cancer) 01/2023 - 10/2013
10	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2011
8	Carcinoma (Carcinomatosis) 03/2023 - 01/2016
7	Adenocarcinoma 07/2022 - 11/2016
7	Cardiotoxicity 05/2016 - 05/2010
6	Leukemia 03/2024 - 05/2010
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2017 - 05/2010
3	Inflammation (Inflammations) 04/2024 - 12/2020
3	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 12/2020
2	Paranoid Disorders (Paranoia) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2018
2	Myocardial Infarction 06/2016 - 04/2016
1	Liver Diseases (Liver Disease) 03/2024
1	Thrombosis (Thrombus) 03/2024
1	COVID-19 12/2023
1	Cicatrix (Scar) 10/2023
1	Virus Diseases (Viral Diseases) 07/2023
1	Cystic Fibrosis (Mucoviscidosis) 07/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2023
1	Circulating Neoplastic Cells 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023

Drug/Important Bio-Agent (IBA)

23	AGRO 100IBA 04/2024 - 05/2016
22	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 01/2018
16	APTIBA 04/2024 - 10/2013
13	Epirubicin (Ellence)FDA LinkGeneric 01/2024 - 09/2013
12	NucleolinIBA 12/2023 - 01/2017
12	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 08/2017
11	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2011
9	GoldIBA 04/2024 - 07/2015
9	Nucleotide AptamersIBA 01/2024 - 06/2015
8	Silicon Dioxide (Silica)FDA LinkGeneric 10/2023 - 06/2017
8	Adenosine Triphosphate (ATP)IBA 01/2023 - 05/2016
8	CamptothecinIBA 01/2022 - 03/2017
6	Hyaluronic Acid (Hyaluronan)IBA 03/2024 - 12/2019
6	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2018
5	PolymersIBA 03/2024 - 03/2019
5	Peptides (Polypeptides)IBA 08/2022 - 01/2018
4	LigandsIBA 01/2024 - 06/2015
4	5TR1 aptamerIBA 01/2024 - 01/2017
4	Mucin-1 (CA 15-3 Antigen)IBA 12/2023 - 04/2019
4	MicellesIBA 01/2022 - 01/2018
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 11/2020
4	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2016 - 05/2010
3	CurcuminIBA 10/2023 - 10/2017
3	Small Interfering RNA (siRNA)IBA 07/2023 - 11/2020
3	IntegrinsIBA 01/2023 - 10/2017
3	Dextrans (Dextran)FDA Link 01/2022 - 10/2017
3	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 06/2017
3	ChitosanIBA 11/2020 - 01/2017
3	Dendrimers (Dendrons)IBA 10/2018 - 05/2016
2	ResveratrolIBA 04/2024 - 12/2020
2	Glycoproteins (Glycoprotein)IBA 01/2024 - 04/2019
2	RNA (Ribonucleic Acid)IBA 12/2023 - 07/2023
2	CollagenIBA 10/2023 - 10/2017
2	EstersIBA 09/2023 - 03/2019
2	OligonucleotidesIBA 07/2023 - 03/2019
2	Therapeutic UsesIBA 07/2023 - 03/2023
2	MicroRNAs (MicroRNA)IBA 07/2023 - 09/2019
2	Cocaine (Cocaine HCl)IBA 01/2023 - 01/2022
2	Nucleic AcidsIBA 08/2022 - 01/2019
2	PicoGreenIBA 08/2022 - 09/2019
2	Cruciform DNA (Holliday Junctions)IBA 08/2022 - 11/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 08/2022 - 09/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 11/2018
2	SurvivinIBA 01/2022 - 11/2020
2	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 12/2020 - 10/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020 - 11/2016
2	EnzymesIBA 09/2020 - 01/2019
2	Melitten (Melittin)IBA 04/2019 - 06/2018
2	graphene oxideIBA 06/2017 - 01/2017
2	MyoglobinIBA 06/2016 - 04/2016
2	AnthracyclinesIBA 01/2016 - 09/2013
1	Methotrexate (Mexate)FDA LinkGeneric 04/2024
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2024
1	Thrombin FDA Link 03/2024
1	PolyethyleneimineIBA 03/2024
1	Citric Acid (Citrate)FDA LinkGeneric 02/2024
1	Phosphates (Orthophosphate)IBA 02/2024
1	BuffersIBA 02/2024
1	cupric sulfide (CuS)IBA 02/2024
1	MucinsIBA 01/2024
1	titanium dioxide (Titania)FDA Link 12/2023
1	CopperIBA 12/2023
1	MXeneIBA 12/2023
1	polyarginineIBA 12/2023
1	VaccinesIBA 07/2023
1	Messenger RNA (mRNA)IBA 07/2023
1	NanoconjugatesIBA 04/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	paclitaxel poliglumex (XYOTAX)IBA 08/2022
1	demplatin pegraglumerIBA 08/2022
1	NK105IBA 08/2022
1	NK911IBA 08/2022

Therapy/Procedure

36	Therapeutics 04/2024 - 10/2013
11	Drug Therapy (Chemotherapy) 12/2023 - 10/2013
11	Precision Medicine 01/2023 - 06/2017
3	Intravenous Injections 12/2023 - 11/2020